Report an error
Spotted something inaccurate in “GLP-1 Receptor Agonists Show No Musculoskeletal Safety Risks Across 100,488 Participants”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.